Pfizer, Inc. (NYSE:PFE) has spent $5.4 million during the third quarter on lobbying the government on topics such as the health care overhaul, government spending on medication, and patent and trade issues. Among many things, the company lobbied on numerous legislations related to the federal health care overhaul. The bills could lead to a greater use of the company’s products, such as the reauthorization of the State Children’s Health Insurance Program.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Pfizer, Inc. is a pharmaceutical company operated worldwide. The company discovers, develops, manufactures and markets prescription medications for humans and animals. The company acquired Encysive Pharmaceuticals, Inc. through a merger of its wholly owned subsidiary, Explorer Acquisition Corp, with and into Encysive in June, 2008. Pfizer also acquired Wyeth in October 2009.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
